This HTML5 document contains 152 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
n9http://dx.doi.org/10.1002/
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q40489054
rdf:type
wikibase:Item
schema:description
სამეცნიერო სტატია artigo científico vitenskapelig artikkel 2006년 논문 2006年学术文章 vedecký článok article scientifique (publié 2006) 2006年學術文章 articolo scientifico 2006年學術文章 artikull shkencor مقالة علمية نشرت في فبراير 2006 ২০০৬-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ บทความทางวิทยาศาสตร์ tieteellinen artikkeli artykuł naukowy наукова стаття, опублікована в лютому 2006 2006 nî lūn-bûn wetenschappelijk artikel мақолаи илмӣ artigo científico (publicado na 2006) 2006年学术文章 мақолаи илмӣ tudományos cikk مقالهٔ علمی научна статия 2006年學術文章 artikulong pang-agham vetenskaplig artikel 2006年学术文章 mokslinis straipsnis artigo científico (publicado na 2006) bilimsel makale articol științific scienca artikolo bài báo khoa học artículo científico publicado en 2006 2006年學術文章 vědecký článek научни чланак 2006年の論文 artículu científicu espublizáu en 2006 vitskapeleg artikkel teaduslik artikkel scientific article научни чланак 2006年學術文章 επιστημονικό άρθρο article científic 2006年学术文章 videnskabelig artikel (udgivet 2006) naučni članak научная статья سائنسی مضمون 2006年學術文章 article scientific מאמר מדעי wissenschaftlicher Artikel գիտական հոդված 2006年学术文章
p:P577
wds:Q40489054-A276F419-8B29-470F-9C42-0D378C8066AB
wdt:P577
2006-02-01T00:00:00Z
p:P407
wds:Q40489054-1D01F3A5-2560-4C8D-8383-E7FA75F61961
wdt:P407
wd:Q1860
p:P2860
wds:Q40489054-752A52D3-B348-415A-8CA0-5DE0797830D7 wds:Q40489054-76413C3C-6C00-44CF-9627-74678895C985 wds:Q40489054-80C1E32F-614A-4A1D-B93A-D56A4741438D wds:Q40489054-9867335A-753F-40CE-8B3D-CA8C257D663E wds:Q40489054-9EAE0C7E-D55A-46E8-BAAC-06D2FC5A80C4 wds:Q40489054-AA3C06ED-8B34-453D-ADA2-0B6CBC73B2D3 wds:Q40489054-4FBE24D4-44BE-47F4-A560-D7D8DF5E863F wds:Q40489054-5C331487-2BA6-44A8-A26D-614AFF13E5CD wds:Q40489054-60171A2D-661D-44F7-B6BB-72227577D20C wds:Q40489054-623960FC-3C29-4BBB-8E6E-6AE3C024AC15 wds:Q40489054-70426EE2-4D14-42CE-997D-0D216A1D48EB wds:Q40489054-286068A8-43E1-497D-ABB7-1C3E5962B8B5 wds:Q40489054-3A9F1905-1C72-481F-A1C5-BAD2503F449A wds:Q40489054-3F748E58-9005-4DBA-BDBE-D1599E7E9992 wds:Q40489054-4D8B4118-ADDE-4BDD-A650-53ACD19B7E8A wds:Q40489054-11CAC113-9A83-4FB3-BDCF-C1CC672B4EE8 wds:Q40489054-130FB814-627D-4E76-8511-8D04E3D4760E wds:Q40489054-175E149D-302C-4C7D-8180-A0E67568457D wds:Q40489054-DDFD5B5F-F64D-47F5-B15E-95ABF3AAAED2 wds:Q40489054-E6971165-93E8-4DEF-A3E1-A855732FCA86 wds:Q40489054-FB52E492-6486-4033-A4CA-B8903264C2BA wds:Q40489054-B890459C-4ED3-4567-8201-A110F4E37444 wds:Q40489054-C0D978F9-F1DC-4915-A17E-D411F654AA02 wds:Q40489054-CD8A098A-8F78-4313-9AEF-8B9111B77490 wds:Q40489054-DD3C033D-059A-4231-A1EE-9E334B991389
wdt:P2860
wd:Q54474339 wd:Q44200289 wd:Q34546077 wd:Q70187571 wd:Q29620739 wd:Q35771142 wd:Q67313964 wd:Q44265645 wd:Q46136376 wd:Q41924796 wd:Q44508371 wd:Q25938997 wd:Q73740462 wd:Q43606238 wd:Q53951659 wd:Q34401962 wd:Q44690362 wd:Q43646333 wd:Q44706045 wd:Q42205274 wd:Q44368521 wd:Q30610198 wd:Q34511480 wd:Q77306436 wd:Q40670736
p:P2093
wds:Q40489054-4533EF83-7290-4AC8-A7E7-198056DB3BC5 wds:Q40489054-414AE006-EA78-4AA3-B314-682FE5560BD5 wds:Q40489054-1486C1FF-00D2-451E-A444-828361B9C06F wds:Q40489054-5FE829E2-03F7-4070-BF22-765FFB1D97F8
wdt:P2093
Ann Mohrbacher Stephanie A Gregory Robert M Rifkin Mohamad A Hussein
rdfs:label
Pegylated liposomal doxorubicin, vincristine, and dexamethasone provide significant reduction in toxicity compared with doxorubicin, vincristine, and dexamethasone in patients with newly diagnosed multiple myeloma: a Phase III multicenter randomized
skos:prefLabel
Pegylated liposomal doxorubicin, vincristine, and dexamethasone provide significant reduction in toxicity compared with doxorubicin, vincristine, and dexamethasone in patients with newly diagnosed multiple myeloma: a Phase III multicenter randomized
schema:name
Pegylated liposomal doxorubicin, vincristine, and dexamethasone provide significant reduction in toxicity compared with doxorubicin, vincristine, and dexamethasone in patients with newly diagnosed multiple myeloma: a Phase III multicenter randomized
p:P1476
wds:Q40489054-CE6E743A-F94A-4712-826E-859C8FBDD230
wdt:P1476
Pegylated liposomal doxorubicin, vincristine, and dexamethasone provide significant reduction in toxicity compared with doxorubicin, vincristine, and dexamethasone in patients with newly diagnosed multiple myeloma: a Phase III multicenter randomized
p:P304
wds:Q40489054-622DBBB1-4A38-45EF-8F55-ECF478606AF2
wdt:P304
848-858
p:P31
wds:Q40489054-E3BD262F-B749-4F08-8C1F-72F045806CC7
wdt:P31
wd:Q13442814
p:P921
wds:Q40489054-23307AB8-316C-439A-9791-36DD4B1514C0 wds:Q40489054-37B34AAE-B1C4-435C-8667-DB17B278869F wds:Q40489054-C23254BB-1544-4514-A8F1-62558E2B4BC7
wdt:P921
wd:Q422252 wd:Q18936 wd:Q6934595
p:P698
wds:Q40489054-BD744272-20A1-4A92-B0CE-8A5966476410
wdtn:P698
n10:16404741
wdt:P698
16404741
p:P1433
wds:Q40489054-0320711F-66E0-450D-8A64-F21C645EB511
wdt:P1433
wd:Q326041
p:P433
wds:Q40489054-2DC6426A-7C43-4B64-A9EB-338CBAA808C7
p:P478
wds:Q40489054-C92FAB94-CBE2-4A83-9274-484B8994220D
wdt:P433
4
wdt:P478
106
p:P356
wds:Q40489054-7F99966D-6E7A-4112-85A7-483250AAF316
wdtn:P356
n9:CNCR.21662
wdt:P356
10.1002/CNCR.21662
p:P5875
wds:Q40489054-6EB47E9E-BD27-427F-92BA-66814549218C
wdt:P5875
7366747